Supernus Pharmaceuticals (SUPN) Share-based Compensation Growth (3y) (2014 - 2026)
Supernus Pharmaceuticals (SUPN) Share-based Compensation Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 10.35% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 24.36% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.84% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 88.54% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 23.49% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 11.76% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 20.51% |
| 10 | Supernus Pharmaceuticals | 2.72 Bn | 2.34 Bn | - | 20.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.54% |
| Dec 31, 2025 | 20.25% |
| Sep 30, 2025 | 2.14% |
| Jun 30, 2025 | -37.12% |
| Mar 31, 2025 | 398.32% |
| Dec 31, 2024 | 36.62% |
| Sep 30, 2024 | 23.98% |
| Jun 30, 2024 | 21.60% |
| Mar 31, 2024 | -15.86% |
| Sep 30, 2023 | -34.51% |
| Mar 31, 2023 | -13.28% |
| Dec 31, 2022 | 66.07% |
| Sep 30, 2022 | -42.07% |
| Jun 30, 2022 | -64.17% |
| Mar 31, 2022 | -79.82% |
| Dec 31, 2021 | -87.94% |
| Sep 30, 2021 | 15.75% |
| Jun 30, 2021 | 21.30% |
| Mar 31, 2021 | 18.38% |
| Dec 31, 2020 | 16.26% |